Our news archive includes ground-breaking news and research from the past 12 months. To make your search easier try to pick a key word or phrase. People often search for ‘MS drugs’ or ‘treatment trials’.
The news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.
Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.
Immune-disorder treatment in mice holds potential for MS patients (25/11/15) A University of Florida Health researcher has found a simple way to treat an immune-related disorder in mice, an approach that could eventually help multiple sclerosis patients...Read more
Study proves cognition tool to be quick and effective (23/11/15) The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is an effective tool in everyday clinical practice for the identification of cognitive impairment (CI) in patients with MS, an Italian study has confirmed...Read more
MS symptoms ‘reduced’ with experimental cancer drug (19/11/15) In mouse models of multiple sclerosis (MS), experimental cancer drugs have shown therapeutic promise, according to findings published in the journal Nature...Read more
Chocolate could reduce MS fatigue, scientists say (17/11/15) Researchers are looking to see whether chocolate can reduce fatigue - one of the most common symptoms in people living with MS...Read more
Vital services face critical challenges, claims report (16/11/15) A report published by the MS Trust has determined that the Britain’s National Health Services (NHS) programs relied upon by people living with multiple sclerosis (MS) are facing increasing pressures that could lead to inequities in care...Read more
Clinical trial results disclosure by drug companies ‘falls below legal and ethical standards’ (13/11/15) Bioethics International, a not-for-profit organisation focused on the ethics and governance of how medicines are researched, developed, marketed and made accessible to patients around the world, has announced the publication of a study ranking large pharmaceutical companies by transparency of clinical trial results...Read more
Cognitive assessment linked to quality of life (13/11/15) Performance in daily activities can be predicted using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) assessment, according to findings published in the Multiple Sclerosis Journal...Read more
Screening for JC virus variants may help PML detection (13/11/15) Prompt detection of the neurotropic variant of the JC virus (JCV) in blood may be a critical step in the prevention of the development of severe progressive multifocal leukoencephalopathy in patients with multiple sclerosis, research published in the European Journal of Neurology indicates...Read more
B-cells ‘responsible for MS activity’ identified (12/11/15) A study from researchers at McGill University in Canada claims to provide new insight into the role of B cells and their complex interaction with other immune cells in the context of MS. The team state that their findings hold great potential for the development of the next generation of targeted treatments that could one day provide a cure for this debilitating disease. The study is published in the journal Science Translational Medicine....Read more
Biomarkers may help detect MS earlier (12/11/15) A new study claims to have identified three proteins that regulate the early stages of multiple sclerosis and hay fever, offering potentially valuable biomarkers for detecting and preventing these immune disorders before patients show signs of disease...Read more
Gilenya ‘prevents activation of key immune cells’ (11/11/15) In a recent study entitled Myeloid Cells As Target Of Gilenya Action In Multiple Sclerosis, a team of scientists investigated the impact of MS treatment Gilenya on the reactivity of myeloid cells, a key group that comprises several immune cells that are activated in MS patients and the underlying cause of the condition. The study was published in the journal Neurology...Read more
Researchers’ blood-brain barrier breakthrough (11/11/15) Canadian scientists have made history with a world first, successfully using focused ultrasound to break through one of the human body's final frontiers - the blood-brain barrier...Read More
Study suggests MS not linked to CCSVI (10/11/15) A new study claims an abnormality in blood drainage from the brain, known as chronic cerebrospinal venous insufficiency (CCSVI), is not associated with multiple sclerosis (MS)...Read more
Higher vitamin D levels may give possible neuroprotection to those with MS (10/11/15) A new study links higher vitamin D levels to possible neuroprotection for individuals with multiple sclerosis...Read More
Immune system ‘modulates’ severity of MS (03/11/15) Multiple sclerosis is thought to be triggered by self-reactive T cells that infiltrate the brain and spinal cord where they launch an aggressive autoimmune attack against myelin, the fatty substance that surrounds and insulates nerve fibers. Over time, the resulting bouts of inflammation permanently damage the myelin sheath and the nerve fibers it protects, disrupting nerve signals traveling to and from the brain...Read more
Sprinter Cox disqualified for being one minute late(30/10/15) Sprinter Kadeena Cox has been disqualified from the IPC Athletics World Championships after she was one minute late to the call room before her T37 200m semi-final in Doha...Read more
New finding will help target MS immune response (29/10/15) Researchers have made another important step in the progress towards being able to block the development of multiple sclerosis and other autoimmune diseases...Read More
HIV drugs helps multiple sclerosis patient walk again (29/10/15) A woman has claimed her multiple sclerosis improved so dramatically she was able to walk again after being prescribed HIV drugs...Read more